retatrutide clinical trial data Phase 3: TRIUMPH Program Results 2026 retatrutide clinical trials data 💉𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀

The question of what separates Foundayo from Rybelsus is one worth answering carefully

Decision factors: Weight loss goals: Want maximum weight loss and can tolerate side effects: Tirzepatide (Zepbound) shows ~4% greater weight loss than semaglutide on average Want proven cardiovascular benefits: Semaglutide has demonstrated 20% reduction in major cardiovascular events in the SELECT trial Want to try oral option: Oral semaglutide (Rybelsus) for diabetes, though weight loss is less than injectable Side effect sensitivity: Some people tolerate one better than the other

Lower doses use more water to enlarge the draw, as the table lists

what we eat, listen to and watch

Glucose-dependent insulinotropic peptide secretion is induced by inflammatory stimuli in an interleukin-1-dependent manner in mice

Retatrutide's GIP component improves tolerability and insulin sensitivity